Sleep Hygiene Education, ReadiWatchTM Actigraphy, And Telehealth Cognitive Behavioral Training For Insomnia Effect, On Symptom Relief For Men With Prostate Cancer Receiving Androgen Deprivation Therapy ADT SHERE-Relief 2.
A Phase I Open-Label, Multi-Center Study of PSMA Targeted Genetically Modified Chimeric Antigen Receptor T Cells in Patients with Metastatic Castration Resistant Prostate Cancer
A Multi-Center, Randomized, Assessor-Blind, Controlled Trial Comparing the Occurrence of Major Adverse Cardiovascular Events MACEs in Patients with Prostate Cancer and Cardiovascular Disease Receiving Degarelix GnRH Receptor Antagonist or Leuprolide GnRH Receptor Agonist
Randomized Phase III Trial Incorporating Apalutamide and Advanced Imaging into Salvage Treatment for Patients with Node-Positive Prostate Cancer after Radical Prostatectomy INNOVATE INtensifying Treatment for NOde Positive Prostate Cancer by VArying the Hormonal ThErapy
Randomized Phase II Trial of Niraparib with Standard Combination Radiotherapy and Androgen Deprivation Therapy ADT in High Risk Prostate Cancer with Initial Phase I NADIR Randomized Phase II Trial of Niraparib with Standard Combination Androgen Deprivation Therapy ADT and Radiotherapy in High Risk Prostate Cancer with Initial Phase I